Validation of a New Hand Held Light Emitting Diode Device for the Determination of Minimal Erythema Dose (MED)
NCT ID: NCT01818154
Last Updated: 2022-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2012-05-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation of a Medical Device, a Mobile Spectrofluorimeter, Measuring Skin Autofluorescence in Healthy Volunteers.
NCT02904616
Respiratory COVID-19: A Randomized, Sham-Controlled Study
NCT05166915
Effectiveness and Safety of CT-guided Needle Placement in the Liver With the Aid of the ActiSight Needle Guidance System
NCT01367392
Temporal Pattern of Circulating DNA for Patients Receiving Irradiation
NCT01099020
Optical Detection of Intravenous Infiltration
NCT01126710
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Minimal Erythema Dose LED
A 2 x 2 cm section of skin will be exposed to LED light.
LED phototherapy
narrowband UVB phototherapy
Minimal Erythema Dose narrow band UVB
A 2 x 2 cm section of skin will be exposed to narrow band UVB light.
LED phototherapy
narrowband UVB phototherapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LED phototherapy
narrowband UVB phototherapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Lactation
3. History of photosensitivity disorder
4. Photosensitizing medications
5. Personal history of melanoma or non-melanoma skin cancer.
6. Skin disease on the back
18 Years
120 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Henry Ford Health System
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Iltefat Hamzavi
Senior Staff Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Iltefat H Hamzavi, M.D.
Role: PRINCIPAL_INVESTIGATOR
Henry Ford Dermatology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Henry Ford Medical Center Department of Dermatology
Detroit, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
7257
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.